Skip to main content
. Author manuscript; available in PMC: 2023 Feb 16.
Published in final edited form as: Alzheimers Dement. 2022 Apr 13;19(2):405–420. doi: 10.1002/alz.12653

Figure 1 |. Reduced clearance of aberrant transcripts by NMD in tau transgenic Drosophila.

Figure 1 |

A) Panneuronal RNAi-mediated reduction of Smg5 limits NMD in Drosophila based on activation of an NMD sensitive reporter. n=6 biological replicates per genotype, per age. B) Panneuronal expression of transgenic human tauR406W limits NMD in Drosophila at day one and day ten of adulthood based on activation of an NMD sensitive reporter. n=6 biological replicates per genotype, per age. Transcript levels of Gadd45 and Arc1 are significantly elevated in Drosophila with panneuronal RNAi-mediated reduction of Smg5 (C) and in tauR406W transgenic Drosophila at day one and day ten of adulthood (D, E). F) Panneuronal expression of transgenic human tauWT limits NMD in Drosophila at day twenty of adulthood based on activation of an NMD sensitive reporter. n=6 biological replicates per genotype. Panneuronal expression of tauWT elevates Gadd45 (G) and Arc1 (H) transcript levels compared to controls. n=12 biological replicates per genotype. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001, unpaired t-test and multiple unpaired t-test. Error bars=SEM. Full genotypes are included in Supplemental Table 1.